Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-29 4:32 pm Purchase |
2025-07-23 | 13G | DEFSEC TECHNOLOGIES INC DFSC |
Mitchell P. Kopin | 71,693 4.990% |
71,693 (New Position) |
Filing History |
| 2025-07-23 5:03 pm Purchase |
2025-07-17 | 13G | Draganfly Inc. DPRO |
Mitchell P. Kopin | 990,228 4.990% |
320,074 (+47.76%) |
Filing History |
| 2025-07-18 5:46 pm Purchase |
2025-07-15 | 13G | Soluna Holdings, Inc. SLNH |
Mitchell P. Kopin | 2,997,785 9.990% |
2,997,785 (New Position) |
Filing History |
| 2025-07-18 5:46 pm Purchase |
2025-07-15 | 13G | 60 Degrees Pharmaceuticals, Inc. SXTP |
Mitchell P. Kopin | 372,429 9.990% |
295,071 (+381.43%) |
Filing History |
| 2025-07-09 4:31 pm Purchase |
2025-07-02 | 13G | Netcapital Inc. NCPL |
Mitchell P. Kopin | 287,877 7.100% |
287,877 (New Position) |
Filing History |
| 2025-07-09 4:29 pm Purchase |
2025-07-02 | 13G | Actelis Networks, Inc. ASNS |
Mitchell P. Kopin | 813,009 7.600% |
813,009 (New Position) |
Filing History |
| 2025-07-08 5:02 pm Purchase |
2025-07-01 | 13G | GeoVax Labs, Inc. GOVX |
Mitchell P. Kopin | 2,792,404 9.990% |
2,792,404 (New Position) |
Filing History |
| 2025-07-08 5:02 pm Purchase |
2025-07-01 | 13G | Cellectar Biosciences, Inc. CLRB |
Mitchell P. Kopin | 140,101 4.990% |
140,101 (New Position) |
Filing History |
| 2025-07-03 5:25 pm Purchase |
2025-06-27 | 13G | Bone Biologics Corporation BBLG |
Mitchell P. Kopin | 153,219 9.990% |
153,219 (New Position) |
Filing History |
| 2025-07-03 5:24 pm Purchase |
2025-06-27 | 13G | Ascent Solar Technologies, Inc. Common Stock ASTI |
Mitchell P. Kopin | 317,830 9.990% |
317,830 (New Position) |
Filing History |
| 2025-07-01 4:44 pm Purchase |
2025-06-25 | 13G | ReWalk Robotics Ltd. LFWD |
Mitchell P. Kopin | 819,443 4.990% |
265,622 (+47.96%) |
Filing History |
| 2025-06-27 5:08 pm Purchase |
2025-06-20 | 13G | SeaStar Medical Holding Corporation ICU |
Mitchell P. Kopin | 1,803,026 9.990% |
1,803,026 (New Position) |
Filing History |
| 2025-06-25 4:38 pm Unchanged |
2025-06-18 | 13G | Aptevo Therapeutics Inc. APVO |
Mitchell P. Kopin | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2025-06-23 06:03 am Purchase |
2025-06-17 | 13G | Processa Pharmaceuticals, Inc. PCSA |
Mitchell P. Kopin | 3,018,238 9.990% |
3,018,238 (New Position) |
Filing History |
| 2025-06-23 06:03 am Purchase |
2025-06-17 | 13G | Adial Pharmaceuticals, Inc. ADIL |
Mitchell P. Kopin | 446,282 2.800% |
446,282 (New Position) |
Filing History |
| 2025-06-13 5:31 pm Purchase |
2025-06-06 | 13G | Venus Concept Inc. VERO |
Mitchell P. Kopin | 120,474 4.990% |
82,698 (+218.92%) |
Filing History |
| 2025-06-13 5:31 pm Purchase |
2025-06-09 | 13G | Nuwellis, Inc. NUWE |
Mitchell P. Kopin | 251,087 4.990% |
251,087 (New Position) |
Filing History |
| 2025-06-13 5:30 pm Purchase |
2025-06-11 | 13G | Draganfly Inc. DPRO |
Mitchell P. Kopin | 670,154 4.990% |
670,154 (New Position) |
Filing History |
| 2025-05-30 5:12 pm Purchase |
2025-05-28 | 13G | Imunon, Inc. IMNN |
Mitchell P. Kopin | 1,111,112 5.500% |
1,111,112 (New Position) |
Filing History |
| 2025-05-27 5:30 pm Purchase |
2025-05-20 | 13G | Jaguar Health, Inc. JAGX |
Mitchell P. Kopin | 65,002 4.990% |
65,002 (New Position) |
Filing History |